Grant: Master's Award - Priority Announcement: HIV Research (SHOPP)
University of British Columbia
$8,750.00
Longitudinal telomere shortening rates in HIV-infected (HIV+) and HIV-exposed uninfected (HEU) children exposed to antiretroviral drugs in utero.
EF 2011-12
Résumé
HIV is a virus that causes immune dysfunction and can be passed from mother to child. People living with HIV age faster but it is unclear whether this is related to HIV infection or to antiretroviral therapy (ART). ART is used to treat HIV+ children and adults. It is also used in HIV+ pregnant women to decrease mother-to-child transmission of the virus, but is known to cross the placenta and expose the foetus to drugs. ART can also inhibit the replication of telomeres that protect the ends of our DNA molecules from damage. Inhibition of telomere replication results in telomere shortening each time a stem cell divides. Short telomeres are linked to shorter life, accelerated aging, and the earlier appearance of age-related illnesses such as cardiovascular and neurodegenerative diseases. HIV itself can also damage telomeres and potentially accelerate aging.
The objective of my project is to investigate the rate of telomere decline over the lifetimes of HIV+ and HIV uninfected (HIV-) children born to HIV+ mothers who were treated with ART during their pregnancy, and compare these to HIV- control children. I will measure telomere length in blood samples that were collected throughout the life of HIV+ children who have never taken ART and compare to HIV+ children who have been on ART almost their whole life and also to HIV- children, born to HIV+ or HIV- mothers. I will try to determine what effect on telomere length is related to the virus or ART, or both. The results from this project will help us understand aging in people living with HIV and may help HIV caregivers to decide when to start or stop ART in HIV+ children or HIV+ pregnant women.
Programme
Master's Award - Priority Announcement: HIV Research (SHOPP)
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
258142
Name
Zanet DeAnna
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
Canadian Association for HIV Research (Ottawa)
Instname2
Aging
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Longitudinal telomere shortening rates in HIV-infected (HIV+) and HIV-exposed uninfected (HEU) children exposed to antiretroviral drugs in utero.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$8,750
Cihrequipment2
$0
Programname2
Master's Award - Priority Announcement: HIV Research (SHOPP)
Keyworddelim
Aging; Antiretroviral Therapy; Genetics; Hiv/Aids; Immunological Cell Separation; Quantitative Pcr; Telomere Attrition
Abstract
HIV is a virus that causes immune dysfunction and can be passed from mother to child. People living with HIV age faster but it is unclear whether this is related to HIV infection or to antiretroviral therapy (ART). ART is used to treat HIV+ children and adults. It is also used in HIV+ pregnant women to decrease mother-to-child transmission of the virus, but is known to cross the placenta and expose the foetus to drugs. ART can also inhibit the replication of telomeres that protect the ends of our DNA molecules from damage. Inhibition of telomere replication results in telomere shortening each time a stem cell divides. Short telomeres are linked to shorter life, accelerated aging, and the earlier appearance of age-related illnesses such as cardiovascular and neurodegenerative diseases. HIV itself can also damage telomeres and potentially accelerate aging.
The objective of my project is to investigate the rate of telomere decline over the lifetimes of HIV+ and HIV uninfected (HIV-) children born to HIV+ mothers who were treated with ART during their pregnancy, and compare these to HIV- control children. I will measure telomere length in blood samples that were collected throughout the life of HIV+ children who have never taken ART and compare to HIV+ children who have been on ART almost their whole life and also to HIV- children, born to HIV+ or HIV- mothers. I will try to determine what effect on telomere length is related to the virus or ART, or both. The results from this project will help us understand aging in people living with HIV and may help HIV caregivers to decide when to start or stop ART in HIV+ children or HIV+ pregnant women.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zanet, DeAnna
Approvedterm
1 an 0 mois
Cihrcontribution2
SPIR~ $8,750~ $0~